No 10Y consistency score yet for revenue — the window needs more comparable quarters.
Valuation vs own 10Y history: P/S N/A · No P/S — trailing revenue unavailable or non-positive.
Chart series for revenue are being prepared.
No 10Y consistency score yet for revenue — the window needs more comparable quarters.
Valuation vs own 10Y history: P/S N/A · No P/S — trailing revenue unavailable or non-positive.
Chart series for revenue are being prepared.
The latest delayed quote for MiniMed Group, Inc. (MMEDV) stock was $20.00 as of Oct 5, 2026, 4:00 PM EDT, unchanged from the previous close.
MiniMed Group, Inc. is a medical technology company that develops, manufactures, and markets a comprehensive suite of solutions for the management of diabetes.
Medical - Instruments & Supplies · Northridge, CA
Next Earnings Date
Dec 30, 2026
85 days away
EPS Estimate
0.14
Revenue Est.
$825.14M
Last Quarter Results
EPS
N/A
vs Estimate
$0.12
Revenue
$843.00M
vs Estimate
$826.80M
| Stock | Market Cap | Close Price | Price Change | TTM Total Return | 5Y CAGR | 10Y CAGR | Compare |
|---|---|---|---|---|---|---|---|
| 1MMEDV | $560.00M | $20.00 | +0.00% | N/A | N/A | N/A | N/A |
| 2CTMX | $562.76M | $2.58 | +0.19% | -21.73% | -12.01% | -16.62% | vs MMEDV |
| 3CRMD | $566.43M | $7.22 | -0.55% | -35.84% | +9.70% | -7.74% | vs MMEDV |
| 4ACRS | $548.84M | $3.93 | -7.97% | +128.66% | -24.23% | -16.23% | vs MMEDV |
| 5BLSM | $548.18M | $18.85 | -5.47% | N/A | N/A | N/A | vs MMEDV |
| 6AQST | $572.76M | $4.57 | -0.11% | -21.12% | +2.24% | N/A | vs MMEDV |
forward FY estimate
N/A
Consensus Rating
No analyst recommendations available
Average Price Target
N/A
Low
N/A
Current
$20.00
High
N/A